Roberto Mignone

Sits on 2 boards. Last updated September 27, 2026

Time on boards

Boards served
2
Current seats
2
Board service
5 years
Director since
2023

5 years of board service in total across 2 boards, counting each seat separately. Longest: Teva Pharmaceutical Industries Limited, 3 years.

3 years ยท Since 2023
1 year ยท Since 2024

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 21, 2026 Guardant Health Inc. Option exercise +264 โ€” โ€”
Sep 18, 2026 Teva Pharmaceutical Industries Limited Open-market sale โˆ’367,600 $39.06 $14,356,802
Aug 21, 2026 Guardant Health Inc. Option exercise +264 โ€” โ€”
Jul 21, 2026 Guardant Health Inc. Option exercise +264 โ€” โ€”
Jun 21, 2026 Guardant Health Inc. Option exercise +264 โ€” โ€”
Jun 17, 2026 Guardant Health Inc. Option exercise +4,203 โ€” โ€”
Jun 5, 2026 Teva Pharmaceutical Industries Limited Option exercise +14,492 โ€” โ€”
May 21, 2026 Guardant Health Inc. Option exercise +264 โ€” โ€”
Apr 21, 2026 Guardant Health Inc. Option exercise +264 โ€” โ€”
Mar 21, 2026 Guardant Health Inc. Option exercise +264 โ€” โ€”
Feb 21, 2026 Guardant Health Inc. Option exercise +264 โ€” โ€”
Jan 21, 2026 Guardant Health Inc. Option exercise +264 โ€” โ€”
Dec 21, 2025 Guardant Health Inc. Option exercise +264 โ€” โ€”
Dec 16, 2025 Teva Pharmaceutical Industries Limited Open-market sale โˆ’77,400 $30.24 $2,340,576
Nov 26, 2025 Teva Pharmaceutical Industries Limited Open-market sale โˆ’50,000 $26.03 $1,301,500

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.